Highly Competent and Safe Titanium(IV) Therapeutic Frameworks that are Cancer Targeted based on Complex 1, 2, and 3D Chemical Architectures

Project Information

TiDrugArchitectures

Grant agreement ID: 681243

DOI

10.3030/681243

Project closed

EC signature date 25 May 2016

Start date 1 June 2016

End date 31 May 2022

Funded under

• EXCELLENT SCIENCE - European Research Council (ERC)

Total cost

€ 2 000 000,00

EU contribution

€ 2 000 000,00

Coordinated by

THE HEBREW UNIVERSITY OF JERUSALEM
Israel

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (8)

Binding of the anticancer Ti(IV) complex phenolaTi to serum proteins: Thermodynamic and kinetic aspects

Author(s): Zohar Shpilt, Edit Y. Tshuva
Published in: Journal of Inorganic Biochemistry, 2022, ISSN 0162-0134
Publisher: Elsevier BV
DOI: 10.1016/j.jinorgbio.2022.111817

Titanium Tackles the Endoplasmic Reticulum: A First Genomic Study on a Titanium Anticancer Metallodrug

Author(s): Maya Miller, Anna Mellul, Maya Braun, Dana Sherill-Rofe, Emiliano Cohen, Zohar Shpilt, Irene Unterman, Ori Braitbard, Jacob Hochman, Edit Y. Tshuva, Yuval Tabach
Published in: iScience, 2020, ISSN 2589-0042
Publisher: Science Direct
DOI: 10.1016/j.isci.2020.101262

Fluorescent antitumor titanium( iv ) salen complexes for cell imaging

Author(s): Avia Tzubery, Naomi Melamed-Book, Edit Y. Tshuva
Published in: Dalton Transactions, Issue 47/11, 2018, Page(s) 3669-3673, ISSN 1477-9226
Publisher: Royal Society of Chemistry
DOI: 10.1039/c7dt04828a

In Vivo Anticancer Activity of a Nontoxic Inert Phenolato Titanium Complex: High Efficacy on Solid Tumors Alone and Combined with Platinum Drugs

Author(s): Nitzan Ganot, Ori Briaitbard, Asaad Gammal, Joseph Tam, Jacob Hochman, Edit Y. Tshuva
Published in: ChemMedChem, Issue 13/21, 2018, Page(s) 2290-2296, ISSN 1860-7179
Publisher: Wiley - V C H Verlag GmbbH & Co.
DOI: 10.1002/cmdc.201800551

Cytotoxic Titanium(IV) Complexes of Salalen-Based Ligands

Author(s): Avia Tzubery, Edit Y. Tshuva
Published in: European Journal of Inorganic Chemistry, Issue 2017/12, 2017, Page(s) 1695-1705, ISSN 1434-1948
Publisher: John Wiley & Sons Ltd.
DOI: 10.1002/ejic.201601200

Racemic vs. enantiopure inert Ti( iv ) complex of a single diaminotetrakis(phenolato) ligand in anticancer activity toward human drug-sensitive and -resistant cancer cell lines

Author(s): Maya Miller, Edit Y. Tshuva
Published in: RSC Advances, Issue 8/69, 2018, Page(s) 39731-39734, ISSN 2046-2069
Publisher: Royal Society of Chemistry
DOI: 10.1039/c8ra08925f

From medium to endoplasmic reticulum: Tracing anticancer phenolato titanium(IV) complex by 19F NMR detection

Author(s): Gilad Nahari, Roy E. Hoffman, Edit Y. Tshuva
Published in: Journal of Inorganic Biochemistry, 2021, ISSN 0162-0134
Publisher: Elsevier BV
DOI: 10.1016/j.jinorgbio.2021.111492

Effective Oral Administration of an AntitumorigenicNanoformulated Titanium Complex

Author(s): Gilad Nahari, Ori Braitbard, Liraz Larush, Jacob Hochman, Edit Y. Tshuva
Published in: ChemMedChem, 2021, ISSN 1860-7187
Publisher: Wiley
DOI: 10.1002/cmdc.202000384